NCT02961738

Brief Summary

Narrative reformulation (NR) is an active ingredient of cognitive analytic therapy (CAT) which is assumed to increase engagement and improve outcomes. This trial sought to test these claims. A randomized and controlled dismantling trial method has been designed to investigate treatments outcomes for depressed patients receiving CAT in an Improving Access to Psychological Therapies service. Participants will be randomized to either treatment as usual (full-CAT) or CAT minus narrative reformulation (CAT-NR). The primary outcome measure is the Patient Health Questionnaire (PHQ-9), with secondary outcome measures of anxiety, functioning, helpfulness and the alliance. Outcomes will be assessed at screening, every treatment session and at 8-weeks follow-up. The trial will enable as assessment of the utility of NR during CAT. and whether CAT appears suitable for treating depression in Primary Care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for phase_2 depression

Timeline
Completed

Started Jan 2011

Typical duration for phase_2 depression

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2015

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

October 20, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 11, 2016

Completed
Last Updated

November 11, 2016

Status Verified

November 1, 2016

Enrollment Period

3 years

First QC Date

October 20, 2016

Last Update Submit

November 10, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in depression at end of treatment via the Patient Health Questionnaire-9 (PHQ-9)

    This measure screens patients in Primary Care for depression. Scores on the PHQ-9 range from 0-27, a score of \>10 on the PHQ9 used as a cut-off point for identifying clinical caseness. The PHQ-9 is widely recognised as a valid and reliable measure of depressive symptoms items mirror DSM criteria for symptoms of depression.

    At 16 weeks.

Secondary Outcomes (4)

  • Change in anxiety at end of treatment via the Generalized Anxiety Disorder-7 (GAD-7)

    At 16 weeks

  • Change in functioning at the end of treatment on the Work and Social Adjustment Scale (WSAS)

    At 16 weeks

  • Change in the therapeutic alliance at the end of treatment on the Working Alliance Inventory-Short (WAI-S)

    At 16 weeks

  • Change in the helpfulness of the therapy via the the Helpful Aspects of Therapy (HAT)

    At 16 weeks

Study Arms (2)

Full-CAT

ACTIVE COMPARATOR

Participants in this arm receive an intervention of a full 8-session course of cognitive analytic therapy (CAT). This means that they are assessed then then receive a narrative reformulation, that then leads onto a sequential diagrammatic reformulation and then the change methods and completion.

Behavioral: Cognitive Analytic Therapy (CAT)

An 8-session CAT without narrative reformulation (CAT-NR)

EXPERIMENTAL

Participants in this arm receive an intervention of a full 8-session course of cognitive analytic therapy (as described above), but crucially with the narrative reformulation (NR) aspect removed. All other aspects of treatment remain the same.

Behavioral: Cognitive Analytic Therapy (CAT)

Interventions

Cognitive Analytic Therapy (CAT) is a relational, integrative and time-limited psychotherapy. This is a study with two active arms. Therefore in the full CAT arm the participants receive the full therapy, but in the CAT-NR arm participants get CAT with the narrative reformulation aspect removed.

An 8-session CAT without narrative reformulation (CAT-NR)Full-CAT

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnosis of depression (conducted using DSM-IV criteria)
  • participants needed to reach caseness (i.e. score 10-21) on the PHQ-9

You may not qualify if:

  • a PHQ-9 score \<10
  • not meeting DSM criteria for depression
  • significant risk issues
  • co-morbid anxiety disorder
  • previous in-patient admission
  • significant amount of previous contact with mental health services
  • visual impairment
  • non-English speaking
  • history of overdoses/self-injury
  • currently abusing substances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Psychology Unit, Department of Psychology, Uni of Sheffield

Sheffield, S10 2TN, United Kingdom

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Glenys Parry, PhD

    Professor of Mental Health

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
IAPT Programme Director and Consultant Clinical Psychologist

Study Record Dates

First Submitted

October 20, 2016

First Posted

November 11, 2016

Study Start

January 1, 2011

Primary Completion

January 1, 2014

Study Completion

January 1, 2015

Last Updated

November 11, 2016

Record last verified: 2016-11

Locations